Prostate Cancer News

Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer ... - MarketWatch (press release)



Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer ... 
MarketWatch (press release)
"We believe ERG testing by IHC and ISH will play an important role in novel diagnostic, prognostic, and predictive tests for prostate cancer," says Mara G. Aspinall, President of Ventana Medical Systems, Inc. "This license gives us a unique position ...

and more » 


Scientists find new type of prostate cancer - discovery may lead to tailored ... - New York Daily News



New York Daily News
 
Scientists find new type of prostate cancer - discovery may lead to tailored ... 
New York Daily News
Scientists in New York and Boston have discovered a new type of prostate cancer that afflicts 15% of patients with the disease ? and it could help doctors tailor treatments. The researchers identified novel mutations in the so-called ?S-Pop? gene and ...
New type of prostate cancer discovered Newstrack India

all 12 news articles » 


Prostate cancer screening test costs Ontario patients $30 - Toronto Star



French Tribune
 
Prostate cancer screening test costs Ontario patients $30 
Toronto Star
Julian Sher Special to the Star When Steven Truscott went to see his doctor last spring and took a blood test to screen for prostate-specific antigen (PSA), he had to pay for it himself. But now that he is diagnosed with cancer, OHIP pays for any ...
Consensus reached on PSA test guidelines Buffalo News
Convict Truscott Fights against Cancer French Tribune
Study Finds Clinical Trials For Cannabis And Prostate Cancer Are Needed THE Weed Blog (blog)

all 6 news articles » 


600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical ... - Reuters



600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical ... 
Reuters
In a crowded prostate cancer space, we also recognize the quality and diligence of the work of our partner Active Biotech to bring new therapies to patients." Marc de Garidel added: "Ipsen is now in the final stage of designing the randomized ...
Ipsen/Active Biotech Phase III prostate cancer study progressing well Pharma Times
Ipsen, Active Biotech Say 600 Patients Recruited In Phase 3 Tasquinimod Study NASDAQ
Active Biotech gets ?10m milestone payment Stock Market Wire

all 20 news articles » 


U.S. House of Representatives' Armed Services Committee And Appropriations ... - MarketWatch (press release)



U.S. House of Representatives' Armed Services Committee And Appropriations ... 
MarketWatch (press release)
The House Armed Services Committee Report accompanying the National Defense Authorization Act for fiscal year 2013 (HR 4310) recognized that "in spite of the magnitude of the prostate cancer epidemic in the military and civilian populations, ...

 


Prostate Cancer Survivor Talks About Diagnosis For Mayor Jones - WCHS



WCHS
 
Prostate Cancer Survivor Talks About Diagnosis For Mayor Jones 
WCHS
A former West Virginia governor says the recent prostate cancer diagnosis for Charleston Mayor Danny Jones should serve as a reminder for everyone about the importance of regular screenings. "The more people who can get examined, the better.

and more » 


Researchers in Galway battle against cancer on many fronts - Irish Times



Irish Times
 
Researchers in Galway battle against cancer on many fronts 
Irish Times
INNOVATION PROFILE: Cancer research at NUI Galway: FOR REASONS which are still a matter of conjecture and research, the people in the west of Ireland have significantly higher rates of breast and prostate cancer than the rest of the Irish population.

and more » 


Treatment of early stage prostate cancer can also result in improved QOL for ... - News-Medical.net



Treatment of early stage prostate cancer can also result in improved QOL for ... 
News-Medical.net
Treatment of early stage prostate cancer can also result in improved quality of life for a subgroup of men who suffer from lower urinary tract symptoms (LUTS), according to an abstract of a Beth Israel Deaconess Medical Center-led study presented to ...

and more » 


Trial Supports Earlier Use of a Prostate Cancer Drug - New York Times



New York Times
 
Trial Supports Earlier Use of a Prostate Cancer Drug 
New York Times
A new drug used to treat advanced prostate cancer may also help men if used early in the course of the disease, before an operation, researchers reported Wednesday. In a small clinical trial, six months of treatment with the drug, Johnson & Johnson's ...
Advanced Prostate Cancer Drug May Help at Earlier Stage U.S. News & World Report
J&J drug shows promise in high-risk prostate cancer Reuters
J&J's Zytiga Helps Eliminate Early-Stage Prostate Cancer Bloomberg
Wall Street Journal  -RTT News  -Daily Mail 
all 43 news articles » 


Convicted Lockerbie bomber dies of cancer in Libya - ABC7Chicago.com



ABC7Chicago.com
 
Convicted Lockerbie bomber dies of cancer in Libya 
ABC7Chicago.com
"I am an innocent man," al-Megrahi insisted, most recently in his final interview in December, in the final stages of prostate cancer. "I am about to die and I ask now to be left in peace with my family." But his death at age 60 leaves no peace for ...
Lockerbie bomber who killed 270 dies of cancer Toledo Blade
Al-Megrahi, convicted in 1988 Lockerbie bombing, dies of cancer Denver Post
Convicted Lockerbie bomber dies of cancer Bend Bulletin

all 3,324 news articles »